Highlights

By Laverne J. Tiffany 4 years ago

− Enrollment Completed in Phase 3 INVIGORATE Trial, with Top-Line Results Expected in the First

By Laverne J. Tiffany 4 years ago

Highlights include continued progress with phase IIb psilocybin therapy clinical trial, launch of first Centre

By Laverne J. Tiffany 4 years ago

With tax time underway, I inspire my fellow tax and accounting experts across the place

By Laverne J. Tiffany 4 years ago

Significant progress advancing IMR-687 as an oral, once-a-day potentially disease modifying treatment for sickle cell

By Laverne J. Tiffany 4 years ago

– Company on track to present data from Phase 2b ReDUX4 trial with losmapimod in

By Laverne J. Tiffany 4 years ago

Orphazyme A/SCompany announcementNo. 06/2021Company Registration No. 32266355 -Advanced arimoclomol in 4 rare disease indications; announced

By Laverne J. Tiffany 4 years ago

Bloomberg Greatest Bitcoin Fund Sinks to Document Lower price as Mania Cools (Bloomberg) — The

By Laverne J. Tiffany 4 years ago

Lund, Sweden, February 26, 2021 – Terranet AB (Terranet/the Business), (Nasdaq: TERRNT-B.ST), developers of sophisticated

By Laverne J. Tiffany 4 years ago

NEW YORK (AP) — A rout in technology businesses pulled the Nasdaq down 3.5% Thursday,

By Laverne J. Tiffany 4 years ago

– Initiated the Phase 2b SOOTHE clinical trial in refractory chronic cough; topline results expected